Growth factors and bone regeneration: how much bone can we expect?
暂无分享,去创建一个
Emil H Schemitsch | Aaron Nauth | E. Schemitsch | B. Ristevski | A. Nauth | Ru Li | Bill Ristevski | Ru Li
[1] Kozo Nakamura,et al. The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2001 by The Endocrine Society Acceleration of Fracture Healing in Nonhuman Primates by Fibroblast Growth Factor-2 , 2022 .
[2] J Alsousou,et al. The biology of platelet-rich plasma and its application in trauma and orthopaedic surgery: a review of the literature. , 2009, The Journal of bone and joint surgery. British volume.
[3] Paolo Cherubino,et al. Recombinant human bone morphogenetic protein-7 for treatment of long bone non-union: an observational, retrospective, non-randomized study of 105 patients. , 2006, Injury.
[4] Kozo Nakamura,et al. A local application of recombinant human fibroblast growth factor 2 for tibial shaft fractures: A randomized, placebo‐controlled trial , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[5] Kozo Nakamura,et al. Single local injection of recombinant fibroblast growth factor‐2 stimulates healing of segmental bone defects in rabbits , 1998, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[6] P. Giannoudis,et al. The Synergistic Effect of Autograft and BMP-7 in the Treatment of Atrophic Nonunions , 2009, Clinical orthopaedics and related research.
[7] S. Santavirta,et al. Recombinant Human Bone Morphogenetic Protein-2 for Treatment of Open Tibial Fractures: A Prospective, Controlled, Randomized Study of Four Hundred and Fifty Patients , 2002, The Journal of bone and joint surgery. American volume.
[8] S. Ahmed,et al. Biology and clinical applications , 2004 .
[9] T. Miclau,et al. Autologous iliac crest bone graft: should it still be the gold standard for treating nonunions? , 2007, Injury.
[10] E H Schemitsch,et al. Fracture vascularity and bone healing: a systematic review of the role of VEGF. , 2008, Injury.
[11] Jay R Lieberman,et al. The role of growth factors in the repair of bone. Biology and clinical applications. , 2002, The Journal of bone and joint surgery. American volume.
[12] P. Giannoudis,et al. Prevalence of long-bone non-unions. , 2007, Injury.
[13] B. Wildemann,et al. Bone morphogenetic proteins in critical-size bone defects: what are the options? , 2009, Injury.
[14] P. Giannoudis,et al. Autologous bone graft: when shall we add growth factors? , 2010, The Orthopedic clinics of North America.
[15] C. Court-Brown,et al. A comparison of RhBMP-7 (OP-1) and autogenous graft for metaphyseal defects after osteotomy of the distal radius. , 2008, Injury.
[16] S. Mirza,et al. Recombinant human BMP-2 and allograft compared with autogenous bone graft for reconstruction of diaphyseal tibial fractures with cortical defects. A randomized, controlled trial. , 2006, The Journal of bone and joint surgery. American volume.
[17] P. Giannoudis,et al. Application of recombinant BMP-7 on persistent upper and lower limb non-unions. , 2005, Injury.
[18] T. Einhorn,et al. Bone morphogenetic proteins in orthopaedic surgery. , 2009, Cytokine & growth factor reviews.
[19] Seong-Ho Choi,et al. Ectopic bone formation associated with recombinant human bone morphogenetic proteins-2 using absorbable collagen sponge and beta tricalcium phosphate as carriers. , 2005, Biomaterials.
[20] J. Watson,et al. Management strategies for bone loss in tibial shaft fractures. , 1995, Clinical orthopaedics and related research.
[21] U. Albisinni,et al. Enhanced tibial osteotomy healing with use of bone grafts supplemented with platelet gel or platelet gel and bone marrow stromal cells. , 2007, The Journal of bone and joint surgery. American volume.
[22] Adam J Starr,et al. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures. , 2003, The Journal of bone and joint surgery. American volume.
[23] P. Giannoudis,et al. Bone morphogenetic proteins in musculoskeletal medicine. , 2009, Injury.
[24] M. Swiontkowski,et al. Recombinant human bone morphogenetic protein-2 in open tibial fractures. A subgroup analysis of data combined from two prospective randomized studies. , 2006, The Journal of bone and joint surgery. American volume.
[25] Johnny Huard,et al. Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. , 2002, The Journal of clinical investigation.
[26] G. Robb,et al. Reconstruction of large diaphyseal defects, without free fibular transfer, in Grade-IIIB tibial fractures. , 1989, The Journal of bone and joint surgery. American volume.
[27] S. Furner,et al. Musculoskeletal Conditions in the United States , 1992 .
[28] A. Mantalaris,et al. Investigating the role of PDGF as a potential drug therapy in bone formation and fracture healing , 2009, Expert opinion on investigational drugs.
[29] N. P. Haas,et al. Quantitative assessment of growth factors in reaming aspirate, iliac crest, and platelet preparation. , 2006, Bone.
[30] Michael J Yaszemski,et al. Effect of local sequential VEGF and BMP-2 delivery on ectopic and orthotopic bone regeneration. , 2009, Biomaterials.
[31] S D Cook,et al. Effect of recombinant human osteogenic protein-1 on healing of segmental defects in non-human primates. , 1995, The Journal of bone and joint surgery. American volume.
[32] J. Poser,et al. Novel formulation of fibroblast growth factor‐2 in a hyaluronan gel accelerates fracture healing in nonhuman primates , 1999, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[33] A. Wentzensen,et al. Treatment of tibial shaft non-unions: bone morphogenetic proteins versus autologous bone graft. , 2009, Injury.
[34] G. Zych,et al. Osteogenic Protein-1 (Bone Morphogenetic Protein-7) in the Treatment of Tibial Nonunions: A Prospective, Randomized Clinical Trial Comparing rhOP-1 with Fresh Bone Autograft* , 2001, The Journal of bone and joint surgery. American volume.
[35] P. Giannoudis,et al. Application of BMP-7 to tibial non-unions: a 3-year multicenter experience. , 2008, Injury.
[36] T. Albert,et al. A Pilot Study Evaluating the Safety and Efficacy of OP-1 Putty (rhBMP-7) as a Replacement for Iliac Crest Autograft in Posterolateral Lumbar Arthrodesis for Degenerative Spondylolisthesis , 2004, Spine.
[37] L. Tagliabue,et al. Application of rhBMP-7 and platelet-rich plasma in the treatment of long bone non-unions: a prospective randomised clinical study on 120 patients. , 2008, Injury.
[38] S. Glassman,et al. Clinical Outcomes and Fusion Success at 2 Years of Single-Level Instrumented Posterolateral Fusions With Recombinant Human Bone Morphogenetic Protein-2/Compression Resistant Matrix Versus Iliac Crest Bone Graft , 2006, Spine.
[39] Emil H Schemitsch,et al. Growth Factors: Beyond Bone Morphogenetic Proteins , 2010, Journal of orthopaedic trauma.
[40] S. Lynch,et al. Recombinant human platelet-derived growth factor: biology and clinical applications. , 2008, The Journal of bone and joint surgery. American volume.
[41] E. Canalis,et al. Effects of basic fibroblast growth factor on bone formation in vitro. , 1988, The Journal of clinical investigation.
[42] V. Bagaria. Re: Vaccaro AR, Patel T, Fischgrund J, et al. A pilot study evaluating safety and efficacy of OP-1 putty (rhBMP-7) as a replacement for iliac crest autograft in posterolateral lumbar arthrodesis for degenerative spondylolisthesis. Spine 2004;29:1885-92. , 2006, Spine.
[43] D. Stewart,et al. Effect of cell‐based VEGF gene therapy on healing of a segmental bone defect , 2009, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[44] Christina Eckhardt,et al. Vascular Endothelial Growth Factor Gene‐Activated Matrix (VEGF165‐GAM) Enhances Osteogenesis and Angiogenesis in Large Segmental Bone Defects , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.